scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q4 EPS of ($0.35), $0.07 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $5.47 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.